Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.013
Neutral
RSI(14)
28.631
Sell
STOCH(KDJ)(9,3,3)
25.462
Neutral
ATR(14)
0.060
Low Volatility
CCI(14)
-209.292
Oversold
Williams %R
89.796
Oversold
TRIX(12,20)
-0.680
Sell
StochRSI(14)
0.000
Sell
Search
Biomerica Inc
BMRAAdd to Watchlist
1.500USD
-0.090-5.65%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.54MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-5.65%
5 Days
-5.36%
1 Month
-14.77%
6 Months
-36.84%
Year to Date
-40.48%
1 Year
-53.70%
Key Figures
1.560Open
1.570High
11.50KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.38%Turnover Ratio
1.590Prev. Close
1.465Low
8.82KTurnover
LossP/E Static
1.37P/B
0.00%Div Yield TTM
-68.12%ROA
4.60052wk High
1.25Volume Ratio
-4.97MNet Profit
3.03MShares
-1.6136EPS TTM
0.30Beta
-94.32%ROE
1.86652wk Low
6.60%Amplitude
-4.46%Gross Margin
4.54MMarket Cap
-2.78Reward/Risk
3.29%Risk Rate
TradingKey Stock Score of Biomerica Inc
Currency: USD Updated: 2026-07-31Key Insights
Biomerica Inc's fundamentals are relatively very healthy, and its growth potential is good.Its valuation is considered fairly valued, ranking 140 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Biomerica Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Biomerica Inc Highlights
StrengthsRisks
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Growing
The company is in a growing phase, with the latest annual income totaling USD 5.31M.
Overvalued
The company’s latest PE is -0.92, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 94.38K shares, decreasing 72.64% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Biomerica Inc News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.578
Sell
MA10
1.589
Sell
MA20
1.628
Sell
MA50
1.888
Sell
MA100
2.025
Sell
MA200
2.248
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Biomerica Inc Info
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Ticker SymbolBMRA
CompanyBiomerica Inc
CEOIrani (Zackary S)
Websitehttps://biomerica.com/
Shareholders
Related Instruments
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Biomerica Inc (BMRA)?
The current price of Biomerica Inc (BMRA) is 1.50.
What is the symbol of Biomerica Inc?
The ticker symbol of Biomerica Inc is BMRA.
What is the 52-week high of Biomerica Inc?
The 52-week high of Biomerica Inc is 4.60.
What is the 52-week low of Biomerica Inc?
The 52-week low of Biomerica Inc is 1.87.
What is the market capitalization of Biomerica Inc?
The market capitalization of Biomerica Inc is 4.54M.
What is the Earnings Per Share (EPS TTM) of Biomerica Inc (BMRA)?
The Earnings Per Share (EPS TTM) of Biomerica Inc (BMRA) is -2.16.